T
Tempest Therapeutics, Inc. (TPST)
NCM – Real Time Price. Currency in USD
1.08
+0.03 (2.86%)
At close: Jun 26, 2026, 4:00 PM EDT
1.08
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:08 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.08
+0.03 (2.86%)
At close: Jun 26, 2026, 4:00 PM EDT
1.08
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:08 PM EDT
No Data
There are no news for this stock.
Total debt $7.9M significantly exceeds cash reserves ($1.8M), raising financial stability concerns
Total current liabilities $3.3M surpass Total current assets $2.4M, signaling liquidity issues
Debt-to-equity ratio (9.6) far exceeds the industry average, reflecting over-leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$7.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.74 | 6.05 | 4.0 | |
| Quick ratio | 0.74 | 5.63 | 4.0 | |
| Debt to Equity | 9.55 | 0.30 | 2.0 | |
| Debt to Assets | 0.73 | 1.04 | 2.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 2.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -2M | -381K | -389K | -266K | -258K |
| Operating Income | -35M | -29M | -42M | -27M | -21M |
| Net Income | -36M | -29M | -42M | -26M | -43M |
| EBITDA | -33M | -29M | -42M | -26M | -21M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 85.51 | 5.5 |
| Next quarter | N/A | 55.7 | 5.5 |
| Current year | N/A | 78.83 | 5.5 |
| Next year | N/A | 9.7 | 3.5 |
| Weighted average score | 5.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -588.77 | -716.12 | -112.58 | 3.3 |
| Y/Y | 999 | -155.02 | 19.94 | 5.45 | 6.3 |
| 3y average | 999 | 4.26 | 42.4 | 3.76 | 7.0 |
| 5y average | 999 | -12.13 | 52.01 | -9.35 | 5.5 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |